Artiva Biotherapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Artiva Biotherapeutics, Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate from Q2 2023 to Q3 2024.
  • Artiva Biotherapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.91M, a 39.1% increase year-over-year.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.91M +$536K +39.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.48M -$975K -39.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-29
Q3 2023 $1.37M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $2.46M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.